1. Smith L, Tully M, Jacob L, Blackburn N, Adlakha D, Caserotti P, Soysal P, Veronese N, Sanchez GFL, Vancampfort D et al: The Association Between Sedentary Behavior and Sarcopenia Among Adults Aged >/=65 Years in Low- and Middle-Income Countries. International Journal of Environmental Research and Public Health 2020, 17(5): 1708.
2. Pang Y, Kartsonaki C, Du H, Millwood IY, Guo Y, Chen Y, Bian Z, Yang L, Walters R, Bragg F et al: Physical Activity, Sedentary Leisure Time, Circulating Metabolic Markers, and Risk of Major Vascular Diseases. Circulation-Genom and Precision Medicine 2019, 12(9):386-396.
3. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, Lancet Physical Activity Series Working G: Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012, 380(9838):219-229.
4. Rosenberg IH: Sarcopenia: origins and clinical relevance. Clinics in Geriatric Medicine 2011, 27(3):337-339.
5. Sinclair AJ, Abdelhafiz AH, Rodriguez-Manas L: Frailty and sarcopenia - newly emerging and high impact complications of diabetes. Diabetes and Its Complications 2017, 31(9):1465-1473.
6. Clark BC, Manini TM: Sarcopenia =/= dynapenia. Gerontology Series A, Biological Sciences and Medical Sciences 2008, 63(8):829-834.
7. Cuthbertson DJ, Bell JA, Ng SY, Kemp GJ, Kivimaki M, Hamer M: Dynapenic obesity and the risk of incident Type 2 diabetes: the English Longitudinal Study of Ageing. Diabetic medicine : A Journal of The British Diabetic Association 2016, 33(8):1052-1059.
8. Mori H, Kuroda A, Ishizu M, Ohishi M, Takashi Y, Otsuka Y, Taniguchi S, Tamaki M, Kurahashi K, Yoshida S et al: Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes. Diabetes Investigation 2019, 10(5):1332-1340.
9. Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, Simonsick EM, Harris TB: Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. Gerontology ： Series A, Biological Sciences and Medical Sciences 2005, 60(3):324-333.
10. Nomura T, Ishiguro T, Ohira M, Ikeda Y: Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes. Diabetes Investigation 2018, 9(1):186-192.
11. Ziegler D, Papanas N, Vinik AI, Shaw JE: Epidemiology of polyneuropathy in diabetes and prediabetes. Handbook Clinical Neurology 2014, 126:3-22.
12. Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L: Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord 2006, 6:19.
13. Tyrberg M, Melander A, Lovestam-Adrian M, Lindblad U: Retinopathy in subjects with impaired fasting glucose: the NANSY-Eye baseline report. Diabetes Obesity & Metabolism 2008, 10(8):646-651.
14. Yang R, Zhang Y, Shen X, Yan S: Sarcopenia associated with renal function in the patients with type 2 diabetes. Diabetes Research and Clinical Practice 2016, 118:121-129.
15. Han P, Kang L, Guo Q, Wang J, Zhang W, Shen S, Wang X, Dong R, Ma Y, Shi Y et al: Prevalence and Factors Associated With Sarcopenia in Suburb-dwelling Older Chinese Using the Asian Working Group for Sarcopenia Definition. Gerontology: Series A, Biological Sciences and Medical Sciences 2016, 71(4):529-535.
16. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB: A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. Gerontology 1994, 49(2):M85-94.
17. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD: Epidemiology of sarcopenia among the elderly in New Mexico. American Journal of Epidemiology 1998, 147(8):755-763.
18. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S et al: Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. American Medical Directors Association 2020, 21(3):300-307 e302.
19. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A et al: Revised equations for estimated GFR from serum creatinine in Japan. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation 2009, 53(6):982-992.
20. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16(1):31-41.
21. American Diabetes A: 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019, 42(Suppl 1):S13-S28.
22. Levin A, Stevens PE: Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Internatinal 2014, 85(1):49-61.
23. Lamb SE, Jorstad-Stein EC, Hauer K, Becker C, Prevention of Falls Network E, Outcomes Consensus G: Development of a common outcome data set for fall injury prevention trials: The Prevention of Falls Network Europe consensus. American Geriatrics Society 2005, 53(9):1618-1622.
24. Delbaere K, Close JC, Kochan NA, Sachdev PS, Lord SR: Good memory as a predictor of falls: fact or artefact. Age and Ageing 2012, 41(3):404-408.
25. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF et al: International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise 2003, 35(8):1381-1395.
26. Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, Albarede JL: The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999, 15(2):116-122.
27. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO: Development and validation of a geriatric depression screening scale: a preliminary report. Psychiatric Research 1982, 17(1):37-49.
28. Calvani R, Joseph AM, Adhihetty PJ, Miccheli A, Bossola M, Leeuwenburgh C, Bernabei R, Marzetti E: Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biological Chemistry 2013, 394(3):393-414.
29. Morley JE, Malmstrom TK, Rodriguez-Manas L, Sinclair AJ: Frailty, sarcopenia and diabetes. American Medical Directors Association 2014, 15(12):853-859.
30. Aleman-Mateo H, Lopez Teros MT, Ramirez FA, Astiazaran-Garcia H: Association between insulin resistance and low relative appendicular skeletal muscle mass: evidence from a cohort study in community-dwelling older men and women participants. Gerontology Series A, Biological Sciences and Medical Sciences 2014, 69(7):871-877.
31. Dalal M, Ferrucci L, Sun K, Beck J, Fried LP, Semba RD: Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. Gerontology Series A, Biological Sciences and Medical Sciences 2009, 64(1):132-137.
32. Tuttle LJ, Sinacore DR, Cade WT, Mueller MJ: Lower physical activity is associated with higher intermuscular adipose tissue in people with type 2 diabetes and peripheral neuropathy. Physical Therapy 2011, 91(6):923-930.
33. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, Palla SL, Ambrosius WT, Tracy RP, Pahor M: Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. The American Journal of Clinical Nutrition 2005, 82(2):428-434.
34. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, Guralnik JM, Ferrucci L: Inflammatory markers and physical performance in older persons: the InCHIANTI study. Gerontology Series A, Biological Sciences and Medical Sciences 2004, 59(3):242-248.
35. Mori H, Kuroda A, Ishizu M, Ohishi M, Takashi Y, Otsuka Y, Taniguchi S, Tamaki M, Kurahashi K, Yoshida S et al: Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes. Diabetes Investigation 2019, 10(5):1332-1340.
36. Zhou Y, Hellberg M, Svensson P, Hoglund P, Clyne N: Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5. Nephrology Dialysis Transplantation 2018, 33(2):342-348.
37. Yanishi M, Kimura Y, Tsukaguchi H, Koito Y, Taniguchi H, Mishima T, Fukushima Y, Sugi M, Kinoshita H, Matsuda T: Factors Associated With the Development of Sarcopenia in Kidney Transplant Recipients. Transplantation proceedings 2017, 49(2):288-292.
38. Domanski M, Ciechanowski K: Sarcopenia: a major challenge in elderly patients with end-stage renal disease. Aging Research 2012, 2012:754739.
39. Ida S, Murata K, Ishihara Y, Imataka K, Kaneko R, Fujiwara R, Takahashi H: A comparison of the associations of dynapenia and sarcopenia with fear of falling in elderly diabetic patients. Nihon Ronen Igakkai Zasshi Japanese Journal of Geriatrics 2017, 54(4):537-545.
40. Scott D, Sanders KM, Aitken D, Hayes A, Ebeling PR, Jones G: Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults. Obesity 2014, 22(6):1568-1574.
41. Hirose D, Hanyu H, Fukasawa R, Namioka N, Hatanaka H, Sato T: Diabetes-related dementia is associated with dynapenia, but not with sarcopenia. Geriatrics &Gerontology International 2017, 17(1):175-177.
42. Gheller BJ, Riddle ES, Lem MR, Thalacker-Mercer AE: Understanding Age-Related Changes in Skeletal Muscle Metabolism: Differences Between Females and Males. Annual Review of Nutrition 2016, 36:129-156.
43. Verschueren S, Gielen E, O'Neill TW, Pye SR, Adams JE, Ward KA, Wu FC, Szulc P, Laurent M, Claessens F et al: Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos International 2013, 24(1):87-98.
44. American Diabetes A: 5. Lifestyle Management: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019, 42(Suppl 1):S46-S60.
45. American Diabetes A: 12. Older Adults: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019, 42(Suppl 1):S139-S147.
46. Lemaster JW, Reiber GE, Smith DG, Heagerty PJ, Wallace C: Daily weight-bearing activity does not increase the risk of diabetic foot ulcers. Medicine and Science in Sports and Exercise 2003, 35(7):1093-1099.
47. Sinclair AJ, Abdelhafiz A, Dunning T, Izquierdo M, Rodriguez Manas L, Bourdel-Marchasson I, Morley JE, Munshi M, Woo J, Vellas B: An International Position Statement on the Management of Frailty in Diabetes Mellitus: Summary of Recommendations 2017. Frailty &Aging 2018, 7(1):10-20.
48. Castro-Rodriguez M, Carnicero JA, Garcia-Garcia FJ, Walter S, Morley JE, Rodriguez-Artalejo F, Sinclair AJ, Rodriguez-Manas L: Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes. American Medical Directors Association 2016, 17(10):949-955.
49. Bjornstad P, Karger AB, Maahs DM: Measured GFR in Routine Clinical Practice-The Promise of Dried Blood Spots. Advances in Chronic Kidney Disease 2018, 25(1):76-83.
50. Lu J, He J, Li M, Tang X, Hu R, Shi L, Su Q, Peng K, Xu M, Xu Y et al: Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults. Diabetes Care 2019, 42(8):1539-1548.
論文の公開元へ
